This course contains 3 sections:
Upon completion of this activity, the learner will be able to:
- Describe the challenges of providing 131I-Metaiodobenzylguanidine (131I-MIBG) therapy to children with neuroblastoma.
- Describe the methods used to conduct this study, including data analysis techniques.
- Differentiate key findings related to the child and the parent experience identified in this study.
- Analyze and apply the study’s findings to improve care of children receiving 131I-MIBG therapy.
Upon successful completion of this course, nurses will earn 1 CNE. There are no pharmacology hours associated with this activity.